Treatment of Bacterial Vaginosis: A Multicenter, Double-Blind, Double-Dummy, Randomised Phase III Study Comparing Secnidazole and Metronidazole

Table 4

Clinical and bacteriological cures at D14 and D28 in the mITT population.

	Clinical cure (%)		Bacteriological cure (%)
	D14	D28	D14	D28
Secnidazole	79.7%	77%	77.5%	70.3%
(𝑛=243)	(𝑛=193)	(𝑛=187)	(𝑛=188)	(𝑛=171)
Metronidazole	77.9%	79.3%	77.3%	71.4%
(𝑛=237)	(𝑛=145)	(𝑛=188)	(𝑛=183)	(𝑛=169)
95% CI Secnidazole-Metronidazole	[−0.056; 0.093]	[−0.098; 0.052]	[−0.073; 0.079]	[−0.093; 0.072]

NS: not significant.